BACKGROUND AND PURPOSE: X-linked α-thalassemia/mental retardation syndrome (Mendelian Inheritance in Man, 301040) is one of the X-linked intellectual disability syndromes caused by mutations of the ATRX gene and characterized by male predominance, central hypotonic facies, severe cognitive dysfunction, hemoglobin H disease (α-thalassemia), genital and skeletal abnormalities, and autistic and peculiar behavior. More than 200 patients in the world, including >70 Japanese patients, have been diagnosed with ATR-X syndrome. MATERIALS AND METHODS: We reviewed the brain MRI and/or CT findings of 27 Japanese patients with ATR-X with ATRX mutations retrospectively. RESULTS: The findings were categorized into 5 types: 1) nonspecific brain atrophy (17/27); 2) white matter abnormalities, especially around the trigones (11/27); 3) widespread and scattered white matter abnormalities (1/27); 4) delayed myelination (4/27); and 5) severe and rapidly progressive cortical brain atrophy (1/27). CONCLUSIONS: This is the first report on a comprehensive study of brain MRI/CT findings of ATR-X syndrome. Our findings suggest that the ATRX protein seems to be involved in normal myelination. The classification will require revisions in the near future, but it will be helpful in establishing the relationship between ATRX mutation and brain development and understanding the ATRX protein function in the brain.
BACKGROUND AND PURPOSE: X-linked α-thalassemia/mental retardation syndrome (Mendelian Inheritance in Man, 301040) is one of the X-linked intellectual disability syndromes caused by mutations of the ATRX gene and characterized by male predominance, central hypotonic facies, severe cognitive dysfunction, hemoglobin H disease (α-thalassemia), genital and skeletal abnormalities, and autistic and peculiar behavior. More than 200 patients in the world, including >70 Japanese patients, have been diagnosed with ATR-X syndrome. MATERIALS AND METHODS: We reviewed the brain MRI and/or CT findings of 27 Japanese patients with ATR-X with ATRX mutations retrospectively. RESULTS: The findings were categorized into 5 types: 1) nonspecific brain atrophy (17/27); 2) white matter abnormalities, especially around the trigones (11/27); 3) widespread and scattered white matter abnormalities (1/27); 4) delayed myelination (4/27); and 5) severe and rapidly progressive cortical brain atrophy (1/27). CONCLUSIONS: This is the first report on a comprehensive study of brain MRI/CT findings of ATR-X syndrome. Our findings suggest that the ATRX protein seems to be involved in normal myelination. The classification will require revisions in the near future, but it will be helpful in establishing the relationship between ATRX mutation and brain development and understanding the ATRX protein function in the brain.
Authors: Richard J Gibbons; Takahito Wada; Christopher A Fisher; Nicola Malik; Matthew J Mitson; David P Steensma; Alan Fryer; David R Goudie; Ian D Krantz; Joanne Traeger-Synodinos Journal: Hum Mutat Date: 2008-06 Impact factor: 4.878
Authors: C Badens; C Lacoste; N Philip; N Martini; S Courrier; F Giuliano; A Verloes; A Munnich; B Leheup; L Burglen; S Odent; H Van Esch; N Levy Journal: Clin Genet Date: 2006-07 Impact factor: 4.438
Authors: Kristin D Kernohan; Yan Jiang; Deanna C Tremblay; Anne C Bonvissuto; James H Eubanks; Mellissa R W Mann; Nathalie G Bérubé Journal: Dev Cell Date: 2010-02-16 Impact factor: 12.270
Authors: Nathalie G Bérubé; Marie Mangelsdorf; Magdalena Jagla; Jackie Vanderluit; David Garrick; Richard J Gibbons; Douglas R Higgs; Ruth S Slack; David J Picketts Journal: J Clin Invest Date: 2005-02 Impact factor: 14.808
Authors: Jonas Straub; Anne Gregor; Tatjana Sauerer; Anna Fliedner; Laila Distel; Christine Suchy; Arif B Ekici; Fulvia Ferrazzi; Christiane Zweier Journal: Sci Rep Date: 2020-01-27 Impact factor: 4.379